Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
52.94
-0.01 (-0.02%)
At close: Apr 28, 2026, 4:00 PM EDT
52.86
-0.08 (-0.15%)
After-hours: Apr 28, 2026, 6:06 PM EDT
Terns Pharmaceuticals Employees
Terns Pharmaceuticals had 59 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
59
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,630,627
Market Cap
6.11B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| Rhythm Pharmaceuticals | 414 |
| Immunovant | 362 |
| Apogee Therapeutics | 261 |
| Cogent Biosciences | 258 |
| Celcuity | 155 |
| CG Oncology | 142 |
| Protagonist Therapeutics | 132 |
TERN News
- 1 day ago - Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia - GlobeNewsWire
- 4 days ago - Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc. - Business Wire
- 13 days ago - Are TERN, SLNO, WSR Obtaining Fair Deals for their Shareholders? - PRNewsWire
- 21 days ago - Merck Lowered Terns Pharmaceuticals Offer Price After Trial Data Review - Benzinga
- 21 days ago - Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc. - Business Wire
- 26 days ago - Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 4 weeks ago - Merck's $6.7 Billion Terns Pharmaceuticals Acquisition May Face Rival Interest: Analyst - Benzinga
- 4 weeks ago - Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline - CNBC